Editas Medicine, Inc. (EDIT)
NASDAQ: EDIT · Real-Time Price · USD
2.420
-0.010 (-0.41%)
At close: Dec 5, 2025, 4:00 PM EST
2.440
+0.020 (0.83%)
After-hours: Dec 5, 2025, 7:34 PM EST
Editas Medicine Market Cap
Editas Medicine has a market cap or net worth of $236.24 million as of December 5, 2025. Its market cap has increased by 15.41% in one year.
Market Cap
236.24M
Enterprise Value
90.24M
1-Year Change
15.41%
Ranking
Category
Stock Price
$2.42
Market Cap Chart
Since February 3, 2016, Editas Medicine's market cap has decreased from $649.70M to $236.24M, a decrease of -63.64%. That is a compound annual growth rate of -9.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 236.20M | 125.38% |
| Dec 31, 2024 | 104.80M | -87.33% |
| Dec 29, 2023 | 827.40M | 35.66% |
| Dec 30, 2022 | 609.90M | -66.42% |
| Dec 31, 2021 | 1.82B | -58.45% |
| Dec 31, 2020 | 4.37B | 187.69% |
| Dec 31, 2019 | 1.52B | 39.66% |
| Dec 31, 2018 | 1.09B | -15.40% |
| Dec 29, 2017 | 1.29B | 122.48% |
| Dec 30, 2016 | 577.90M | -11.05% |
| Feb 3, 2016 | 649.70M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.62B |
| Johnson & Johnson | 486.51B |
| AbbVie | 399.57B |
| UnitedHealth Group | 299.75B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 247.51B |
| Abbott Laboratories | 217.50B |